<

UCB (EBR:UCB) UCB Media Room: Acquisitions and disposals of own shares

Transparency directive : regulatory news

11/06/2020 20:00
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jvMSFRv1ag-2FzyRNf0cQ629iGHgstdWg= PIqlLyHfVL8xeSGCjhpjWR4BihxvdnfBQsJ2nv_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7= KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1= wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMK= wi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZTycxmY8SJKhIQVC4pP-2FZU-2FhlRmtc2bePl66wqN= ukwVgGLHv-2B7nRhe0-2FT7kTjkfvAF9Mezl-2Fcts1EEP-2BGGEsjSDUHuab9hdeVikFnDLp5b= 4Kq2bA8p9EXSWAgIU0YJpMfK0X6yGDXu9I9ude-2F8iHY9A-3D ** Acquisitions and disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 11 June 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regulated= information Acquisitions of own shares In accordance with article 8:4 of the Royal Decree of 29 April 2019 executi= ng the Belgian Code on Companies and Associations, UCB SA/NV (=E2=80=9CUCB= =E2=80=9D or the =E2=80=9CCompany) (Euronext Brussels: UCB) hereby disclose= s certain information in relation to its Share Repurchase Program 2020.=C2= =A0 Under this program, UCB has requested a financial intermediary to repurchas= e up to 1.2 million UCB shares on its behalf under the terms of an initial = discretionary mandate agreement with validity until 15 June 2020, effective= as from 25 March 2020, to cover current and future obligations under UCB's= Long Term Incentive Plans for its personnel. The validity of this agreemen= t has been extended from 15 June 2020 to 29 July 2020. In the framework of this Share Repurchase Program 2020, UCB repurchased 209= 412 UCB shares on Euronext Brussels in the period from 2 June 2020 up to a= nd including 10 June 2020, as follows:=C2=A0 =C2=A0 https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jmy8CAhKLmmKN4h9m87UQGSozSO-2BzIz= 65ZEA9UNlHdnFSsLPl4b5YlR6nqip9xevxBsWH_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7= KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1= wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMK= wi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZbdVuY-2BG-2BS68DUbakiiUbkqcqagaJqCa-2BCaL5= z-2FGCFGiwZvGb3XwsEsbv7AHsIHWeqLpJ0H-2BQeJ9r91KF8NApvC7nxxmVIY2C21Us1I-2FYr= Hy96XqEiV3qLHq-2FWHMLGUZXv171wNkwobbzs785CaDW9k-3D =C2=A0 =C2=A0Disposals of own sharesIn accordance with article 8:6 of the Royal De= cree executing the Belgian Code of Companies and Associations, UCB announce= s that, following exercises of stock options by members of its personnel, i= t has disposed of UCB shares OTC in view of deliveries of these shares to t= he relevant members of the personnel, within the framework of the Long Term= Incentive Program of the UCB Group, as follows: =C2=A0 https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jmuuA5t6a65-2BMxOviABIAjtUdyL9zYH= HlF-2BSlbVgbirnZODyYr8398iPgnz6xiewvxKi__xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW= u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9= g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmR= MKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZVmtu3qQqTo0VD1Uave5FKt7VMqkpPOfonYg-2FW6= iC3g-2Bd4nracqLSLgtRkevgSUlQudo8lE9CCubaskpN2bTcQQVvvALyRWjIh-2FFgpwm4VpQp2= AkCWNCCIRs1UK7SVu37M52CtI-2F0Rjqpb52S99beGY-3D This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ= yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1= 8dK5MiuQ-3D-3Dgm8z_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS= l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1Hx= yuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEY= ju79s6plkNQ3ZbVN8PgjEBK4UjtrV0ayZF-2FBlUqRJb4929ZRlpQyOaDu0xslUqbUkVgzoHkUy= BquTfgXnJu8jE-2FPucTMkDK4T47LjbnrV-2FbnOxApNl6tQ8zBdDCoJGxwmgGxeyEN5lvbXNSg= AwdMRCuBZJAtG6-2FbQps-3D . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i= n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news GenericFile 2020611 - UCB Acquisitions and disposals of own shares (https://u7061146.ct= .sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B= 6enP299YDZ6RaBZwFkRnmx8j2S-2BbOYG6wnbCfnKAbrJCAHv5wDZ0tCHEFxYPLhbZVfs-3D2nP= e_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-= 2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8= z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZT6Qu= l8OpsJvwzivYPqD3CNsaIfojalriawYI-2Fa2tPcUu8am1ZLG0MAkLlfK9tBdTBYpjlap8JSK1A= gkSFgaYka-2BnmlabGkT4kqF4ejptIehqNtmihHVsZFq1tZv-2FmAkwKzknzUaiES21Ol-2F5js= 9E3w-3D GenericFile 2020611 - UCB Acquisitions and disposals of own shares (https://u7061146.ct= .sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B= 6enP299YDZ6RaBZwFkRnmx8j1AHYIVpY9AUL8IoXfvwu1RIo9hMTmsQznqq0J1i96Ng-3DOo___= xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2F= BZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5= BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3Zdnp5Nf= CfzjcgZD1nT9e91Krb4njTrHtThc4w8CV9mJLR4ociVaXaFEP7hSrRaXT-2Fh-2B61aUi1zsGXG= 3WJWTwWC-2Brm7lIaslH0SDiOGw8Qw7g7AhDz-2FXoYESGI-2FMUNAUOFMWfBdU60maK4yU17rL= VipQ-3D GenericFile 20200611 - Verwerving en vervreemding van eigen aandelen (https://u7061146.= ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-= 2B6enP299YDZ6RaBZwFkRnmx8jTY68IK9UyY1eUD-2Fhh6qkXhpnknqdBeEsP0HbmIdfhww-3Do= 9S2_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqdd= W-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04Wwej= U8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3Zd6= bA0EGS-2FY-2BXbaPAlhF7DeMkAlOBMEvjkq3m8D8Ktwws-2BY5Y8u37H2HvWENkfy0JMN0Ksvd= 52NmzWCTHHGZkVauZZ0ni433sqT6rNJ7ABd0v6pHYRUDpVHen0c4oihPQqkJ92PiXnGMhzXjFMI= DVa8-3D Image Chart 1 June 11 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED= -2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jmy8CAhKLmm= KN4h9m87UQGSwgazbexVt0BOyJCd9fS6c-3DP1SF_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW= u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9= g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmR= MKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZY0l1Xsj5PMcnoMUVkAHOH3cjOxhSYLbQTrq-2FDk= 0WhzMNEfYsoJtwpfiUzFaY7zbAe4Cl9m8UQsPFRes8m8leLs9dokRj6hI31Vc58G6wD7-2FV5-2= FfZm-2F78twvYEMT6I7kZCegUeR1AOgp7ilsgu8-2Bsv0-3D Image Chart 2 June 11 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED= -2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6enP299YDZ6RaBZwFkRnmx8jmuuA5t6a65= -2BMxOviABIAjpdKt282yjcPazpMy7-2Bn4sM-3DoFGE_xDPID0vOuylFAU8fv4e60wei4JxqEG= BdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2= X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1Mm04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4B= kAmRMKwi5XZ597sHDVEeaH3WEYju79s6plkNQ3ZQPBfOPoo2M2Jv-2FcMAO7eMj2foyODuCvmp8= XcCA1fVN6fIEhEANvs-2BJhQNhKA7IvIbF1TI73pxKvIAUXUyxHTh4irnwidk0tHIm-2FagXct6= l1oh2ikecnP1f4L0i3Oq8lVdh82qUx9uvFmWWa1WxhAGA-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT= UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXzSjPqWpnrXN0g3pTsGoenfcG7hGuAsH= s63OWpKhf0Lp2mkE5CumwzyZvGTQhVSPnfOdp9Bh3jSqeB71A1-2BlGh5Bf65JAY3ueDqRD7lrc= XaY-3D227d_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6= EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wYGTTIGOuCHDA8MWp1HxyuEuJm1M= m04WwejU8z5BKsxOe8DZ6gMgaJikkIDFlO7KdfA4BkAmRMKwi5XZ597sHDVEeaH3WEYju79s6pl= kNQ3ZSCUBhO9Hi3wDWF9L9Yvs67B-2BBAEbPxLeia09S9NmRigGYUOoPd1iWWflJ2rgrs7ZnK7P= I3fv-2Fkddh94-2Bqvy1bgKNmcTemF-2BrkRdjo3Qst541q0zuX0MccETaCDtK6FiCgTpxB3w1M= t3eP32K5ZsWNw-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=


Other stories

25/04/2024 13:15
25/04/2024 13:03
25/04/2024 10:14
25/04/2024 10:00
25/04/2024 09:43
25/04/2024 11:13
25/04/2024 09:31
25/04/2024 11:29
25/04/2024 11:52
25/04/2024 13:22
25/04/2024 12:12
24/04/2024 19:01
25/04/2024 13:11
25/04/2024 12:31
25/04/2024 14:10
25/04/2024 09:30
25/04/2024 14:05
25/04/2024 11:44
25/04/2024 08:39
25/04/2024 08:13
24/04/2024 18:09
24/04/2024 19:50
25/04/2024 09:01
25/04/2024 11:04
25/04/2024 11:53
25/04/2024 06:00
25/04/2024 10:15
25/04/2024 14:22
25/04/2024 09:00
25/04/2024 13:00
24/04/2024 20:00
24/04/2024 18:04
24/04/2024 06:28
25/04/2024 07:30
25/04/2024 06:00
24/04/2024 16:48
24/04/2024 14:21
24/04/2024 23:40